In the United States, three monoclonal antibody therapies targeting SARS-CoV-2 are available for the treatment of non-ho

Business, Finance, Economics, Accounting, Operations Management, Computer Science, Electrical Engineering, Mechanical Engineering, Civil Engineering, Chemical Engineering, Algebra, Precalculus, Statistics and Probabilty, Advanced Math, Physics, Chemistry, Biology, Nursing, Psychology, Certifications, Tests, Prep, and more.
Post Reply
answerhappygod
Site Admin
Posts: 899603
Joined: Mon Aug 02, 2021 8:13 am

In the United States, three monoclonal antibody therapies targeting SARS-CoV-2 are available for the treatment of non-ho

Post by answerhappygod »

In the United States, three monoclonal antibody therapies
targeting SARS-CoV-2 are available for the treatment of
non-hospitalized adults (≥18 years of age) and children (≥12 years
of age weighing at least 40 kg) with mild to moderate COVID-19 and
specific risk factors for severe disease. This monclonal antibody
therapy refers to the 3 vaccines (Moderna, Pfizer and J&J)
currently available in the USA.
True or false
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!
Top
Post Reply

Return to “Archived Questions & Answers”